Immunome Q2 EPS $(0.65) Misses $(0.52) Estimate
Immunome (NASDAQ: IMNM ) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.52) by 25 percent. This is a 30 percent decrease over losses of $(0.50) per share from the same period last year.